Camber Capital Management as of June 30, 2011
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 44 positions in its portfolio as reported in the June 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sanofi-Aventis SA (SNY) | 6.8 | $54M | 1.4M | 40.17 | |
| CVS Caremark Corporation (CVS) | 6.4 | $51M | 1.4M | 37.58 | |
| Amgen (AMGN) | 5.9 | $47M | 800k | 58.35 | |
| Tenet Healthcare Corporation | 4.7 | $37M | 6.0M | 6.24 | |
| CareFusion Corporation | 4.6 | $37M | 1.4M | 27.17 | |
| Sanofi Aventis | 4.5 | $36M | 900k | 40.17 | |
| Acorda Therapeutics | 4.2 | $33M | 1.0M | 32.31 | |
| Eli Lilly & Co. (LLY) | 4.0 | $32M | 850k | 37.53 | |
| Quest Diagnostics Inc option | 3.7 | $30M | 500k | 59.10 | |
| Quest Diagnostics Inc put | 3.7 | $30M | 500k | 59.10 | |
| LifePoint Hospitals | 3.4 | $27M | 700k | 39.08 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.3 | $26M | 500k | 51.99 | |
| Health Management Associates | 2.7 | $22M | 2.0M | 10.78 | |
| Medco Health Solutions | 2.5 | $20M | 350k | 56.52 | |
| Cvs Caremark Corporation option | 2.4 | $19M | 500k | 37.58 | |
| Lilly Eli & Co option | 2.4 | $19M | 500k | 37.53 | |
| Alere | 2.3 | $18M | 500k | 36.62 | |
| Conceptus | 2.2 | $18M | 1.5M | 11.67 | |
| Auxilium Pharmaceuticals | 2.2 | $17M | 887k | 19.60 | |
| Boston Scientific Corporation (BSX) | 2.2 | $17M | 2.5M | 6.91 | |
| Wright Medical | 2.1 | $17M | 1.1M | 15.00 | |
| Universal American | 2.0 | $16M | 1.5M | 10.95 | |
| SonoSite | 1.9 | $15M | 428k | 35.17 | |
| AngioDynamics (ANGO) | 1.8 | $15M | 1.0M | 14.23 | |
| St. Jude Medical | 1.8 | $14M | 300k | 47.68 | |
| Cardionet | 1.5 | $12M | 2.3M | 5.31 | |
| Rite Aid Corporation | 1.5 | $12M | 9.1M | 1.33 | |
| Forest Laboratories | 1.5 | $12M | 300k | 39.34 | |
| Hospira | 1.4 | $11M | 200k | 56.66 | |
| United Therapeutics Corporation (UTHR) | 1.4 | $11M | 200k | 55.10 | |
| AMAG Pharmaceuticals | 1.2 | $9.8M | 523k | 18.80 | |
| ArthroCare Corporation | 1.2 | $9.5M | 284k | 33.47 | |
| Savient Pharmaceuticals | 1.2 | $9.4M | 1.3M | 7.49 | |
| Teleflex Incorporated (TFX) | 1.1 | $9.2M | 150k | 61.06 | |
| Alnylam Pharmaceuticals (ALNY) | 1.1 | $9.2M | 980k | 9.37 | |
| Allos Therapeutics | 1.1 | $8.6M | 4.0M | 2.14 | |
| Dynavax Technologies Corporation | 0.6 | $5.0M | 1.8M | 2.75 | |
| Cross Country Healthcare (CCRN) | 0.3 | $2.6M | 343k | 7.60 | |
| Dynavax Technologies Corporation | 0.3 | $2.3M | 1.7M | 1.34 | |
| Anthera Pharmaceuticals | 0.3 | $2.1M | 400k | 5.20 | |
| Celgene Corp right 12/31/2011 | 0.2 | $1.9M | 949k | 2.05 | |
| WorldHeart Corporation (WHRT) | 0.2 | $1.6M | 1.6M | 1.00 | |
| ViroPharma Incorporated | 0.0 | $36M | 1.9M | 18.69 | |
| WorldHeart Corporation (WHRT) | 0.0 | $33k | 1.6M | 0.02 |
